After publication, 340B Report received the following comment from Eli Lilly and Co. on its actions that we reported on today:
…Report after report shows 340B is not working for patients and needs reform. We support recent executive action on
Category: Breaking
Breaking News
BREAKING: Kalderos Wants to Give Drug Manufacturers a Way to Pay 340B Rebates in Lieu of Discounts
A Message from Publisher and CEO Ted Slafsky: I hope all is well. For now, we have more requests for 340B Report sponsorships than space available. Fortunately, we are creating a new website and newsletter platform that will accommodate our growing
…Breaking News
BREAKING: AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy
AstraZeneca Raises the Ante in Drug Industry Push Against 340B Contract Pharmacy
Drug manufacturer AstraZeneca today sent letters to 340B covered entities and its wholesale pharmacy contacts telling them that, effective Oct. 1, it
…Breaking News
BREAKING: Omnicell Buys PSG’s 340B Line of Business, the Latest in a Trend of 340B TPA Acquisitions
Omnicell Buys PSG’s 340B Line of Business, the Latest in a Trend of 340B TPA Acquisitions
Omnicell Inc., a leading provider of automated drug dispensing systems and other prescription drug supply chain products and services, has agreed to buy Pharmaceutical
…Breaking News
BREAKING: Health Centers Challenge Administration Suggestions They Put 340B Profits Over Patients
Health Centers Challenge Administration Suggestions They Put 340B Profits Over Patients
The nation’s community health centers last night struck back against a presidential executive order and Trump administration comments that
…Breaking News
BREAKING: Presidential Executive Order Targets 340B Health Centers’ Savings on Insulin and EpiPen
Presidential Executive Order Targets 340B Health Center’ Savings on Insulin and EpiPen
Update, 9:50 p.m. EDT, July 24—National Association of Community Health Centers President and CEO Tom Van Coverden issued
…Hospitals and Other Providers Ask HHS to Halt Lilly and Merck’s Clampdowns on 340B; Companies Defend Their Positions
The U.S. Health and Human Services Department (HHS) should halt drug manufacturers Eli Lilly and Merck’s recent separate actions to curtail or
…Breaking News
BREAKING: New U.S. Senate Bipartisan Bill Would Preserve Hospitals’ 340B Eligibility During Pandemic
New U.S. Senate Bipartisan Bill Would Preserve Hospitals’ 340B Eligibility During Pandemic
New bipartisan legislation in the U.S. Senate would “would provide certainty to hospitals participating in the 340B drug discount program during the COVID-19 public health emergency,” its
…
